Pseudomyogenic hemangioendothelioma with bone and soft tissue involvement with favorable response to pamidronate: a case report and systematic review of the literature-Reference-Cited by-同舟云学术

Pseudomyogenic hemangioendothelioma with bone and soft tissue involvement with favorable response to pamidronate: a case report and systematic review of the literature

Published:2022-02-01 Issue:1 Volume:17 Page:
ISSN:1862-3522
Container-title:Archives of Osteoporosis
language:en
Short-container-title:Arch Osteoporos

Author:

Brance María Lorena,Cóccaro Nicolás M.,Roitman Pablo,Castiglioni Alejandro,Agostinis Florencia,Spense Mariel,Scheitlin Bárbara,Rene Nicholas,Brun Lucas R.

Publisher

Springer Science and Business Media LLC

Subject

Orthopedics and Sports Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11657-022-01062-4.pdf

Reference52 articles.

1. Mirra JM, Kessler S, Bhuta S, Eckardt J (1992) The fibroma-like variant of epithelioid sarcoma: a fibrohistiocytic/myoid cell lesion often confused with benign and malignant spindle cell tumors. Cancer 69:1382–1395

2. Billings SD, Folpe AL, Weiss SW (2003) Epithelioid sarcoma-like hemangioendothelioma. Am J Surg Pathol 27:48–57. https://doi.org/10.1097/00000478-200301000-00006

3. Hornick JL, Fletcher CD (2011) Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior. Am J Surg Pathol 35:190–201. https://doi.org/10.1097/PAS.0b013e3181ff0901

4. Jo VY, Fletcher CD (2014) WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology 46:95–104. https://doi.org/10.1097/PAT.0000000000000050

5. Amary MF, O’Donnell P, Berisha F et al (2013) Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma: characterization of five cases. Skeletal Radiol 42:947–957. https://doi.org/10.1007/s00256-013-1577-8

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary vascular tumors of bone: A comprehensive literature review on classification, diagnosis and treatment;Critical Reviews in Oncology/Hematology;2024-03

2. Pazopanib as Treatment Option for Pseudomyogenic Hemangioendothelioma: A Case Report;Cureus;2022-05-23